Dr. Charles Cobbs, The Gregory Foltz Endowed Director of the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment at Swedish Neuroscience Institute Awarded $50,000 grant by The Musella Foundation

  Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   I am very excited to announce that my research group has been awarded a research grant from The Musella Foundation for Brain Tumor Research and Information, Inc., which will allow […]

New Brain Cancer Treatment Targets Tumor Hypoxia To Increase Benefits of Radiation Therapy

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists The most important aspect of treatment for glioblastoma is radiation treatment. Radiation probably has more of an impact on overall survival than surgery or chemotherapy. However, radiation works by breaking bonds of […]

Avastin rejected by EMA for Treatment of Glioblastoma

  Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   The advisers to the European Medicines Agency have recommended against expanding Avastin to treat glioblastoma.  http://www.pharmatimes.com/Article/14-05-25/EMA_advisors_reject_Avastin_for_brain_cancer.aspx While Avastin is used generously in the United States for glioblastoma, and can induced […]

Update on Phase II Trial by Immunocellular Therapeutics ICT 107 for Newly Diagnosed Glioblastoma

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   A recent presentation at the American Society for Clinical Oncology  (ASCO) meeting in Chicago this month shows some suggestion of efficacy of the ImmunoCellular Therapeutics immunotherapy vaccine ICT-107.   http://www.marketwatch.com/story/immunocellular-therapeutics-presents-updated-ict-107-phase-ii-data-in-patients-with-newly-diagnosed-glioblastoma-at-the-2014-asco-annual-meeting-2014-06-01  The vaccine […]